Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome

Table 3 Predictors of the minimal important change in health-related quality of life at 6 months after PCI

Variables	Multivariate logistic regression
Variables	OR	95% CI	p value
PCS
Female	0.93	0.67–1.44	0.10
Age	0.82	0.35–2.08	0.23
Diabetes	0.97	0.63–1.82	0.77
Hypertension	0.92	0.55–2.96	0.86
Clinical presentation	1.78	0.42–3.20	0.83
Cardiac rehabilitation	1.79	0.98–2.31	0.07
Any BARC bleeding	0.89	0.62–1.46	0.41
Ticagrelor use	1.21	0.97–2.07	0.89
Baseline PCS score	1.98	1.35–2.93	0.03
Baseline MCS score	1.49	1.22–2.45	0.04
MCS
Female	0.82	0.40–1.91	0.09
Age	0.80	0.28–1.02	0.07
Diabetes	0.74	0.46–1.89	0.16
Hypertension	0.81	0.44–2.09	0.23
Clinical presentation	0.77	0.57–2.42	0.21
Cardiac rehabilitation	1.99	1.04–2.51	0.08
Any BARC bleeding	0.65	0.36–1.74	0.11
Ticagrelor use	1.12	0.72–1.97	0.86
Baseline PCS score	2.18	0.98–3.36	0.06
Baseline MCS score	2.55	1.11–3.80	0.02

BARC, Bleeding Academic Research Consortium; MCS, mental component summary; PCS, physical component summary

ISSN: 1477-7525